[go: up one dir, main page]

PA8776001A1 - NEW DROSPIRENONA REGIME / 17b- ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND ELEMENT ASSEMBLY (KIT) FOR APPLICATION - Google Patents

NEW DROSPIRENONA REGIME / 17b- ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND ELEMENT ASSEMBLY (KIT) FOR APPLICATION

Info

Publication number
PA8776001A1
PA8776001A1 PA8776001A PA8776001A PA8776001A1 PA 8776001 A1 PA8776001 A1 PA 8776001A1 PA 8776001 A PA8776001 A PA 8776001A PA 8776001 A PA8776001 A PA 8776001A PA 8776001 A1 PA8776001 A1 PA 8776001A1
Authority
PA
Panama
Prior art keywords
combined pharmaceutical
estradiol
pharmaceutical product
daily dosage
drospirenona
Prior art date
Application number
PA8776001A
Other languages
Spanish (es)
Inventor
Duesterberg Bernd
Schuermann Rolf
Blode Hartmut
Hanes Vladimir
Marr Joachim
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of PA8776001A1 publication Critical patent/PA8776001A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN PRODUCTO FARMACEUTICO COMBINADO DE AL MENOS 21 UNIDADES DE DOSIFICACION DIARIAS CONSECUTIVAS QUE CONTIENEN ENTRE 2,0 MG Y 3,0 MG DE DROSPERINONA Y ENTRE 1,0 Y 2,O MG DE 17ß-ESTRADIOL EN CADA UNIDAD DE DOSIFICACION DIARIA SEGUIDO POR UNIDADES DE DOSIFICACION DIARIAS INTERMITENTES QUE CONTIENEN LA MISMA CANTIDAD, O UNA CANTIDAD MENOR, DE DROSPERINONA /ES DECIR, ENTRE 0,5 MG Y 3,0 MG) COMO UNIDADES DE DOSIFICACION DIARIAS CONSECUTIVAS, EN DONDE CADA UNIDAD DE DOSIFICACION DIARIA INTERMITENTE ESTA PRECEDIDA POR AL MENOSUN DIA SIN ADMINISTRACION DE DROSPERINONA. ESTOS PRODUCTOS FARMACEUTICOS COMBINADOS SE PUEDEN USAR EN LA CONTRACEPCION ORAL FEMENINA, PUEDEN ASEGURAR UN SANGRADO POR DEPRIVACION CADA 4 SEMANAS Y PERMITIR EL MANTENIMIENTO COMPLETO DE LOS BENEFICIOS RELACIONADOS CON LA DROSPERINONA.A COMBINED PHARMACEUTICAL PRODUCT OF AT LEAST 21 CONSECUTIVE DAILY DOSAGE UNITS CONTAINING BETWEEN 2.0 MG AND 3.0 MG OF DROSPERINONE AND BETWEEN 1.0 AND 2, OR MG OF 17ß-ESTRADIOL IN EACH DAILY DOSAGE UNIT FOLLOWED BY UNITS OF INTERMITTENT DAILY DOSAGE CONTAINING THE SAME QUANTITY, OR A MINOR AMOUNT, OF DROSPERINONE / SAY, BETWEEN 0.5 MG AND 3.0 MG) AS CONSECUTIVE DAILY DOSAGE UNITS, WHERE EACH INTERMITTENT DAILY DOSING UNIT IS PRECEDED BY AT LEAST DAY WITHOUT ADMINISTRATION OF DROSPERINONA. THESE COMBINED PHARMACEUTICAL PRODUCTS CAN BE USED IN FEMALE ORAL CONTRACEPTION, MAY ENSURE BLEEDING BY DEPRIVATION EVERY 4 WEEKS AND ALLOW THE FULL MAINTENANCE OF DROSPERINONE-RELATED BENEFITS.

PA8776001A 2007-04-05 2008-04-07 NEW DROSPIRENONA REGIME / 17b- ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND ELEMENT ASSEMBLY (KIT) FOR APPLICATION PA8776001A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91032607P 2007-04-05 2007-04-05
US3528508P 2008-03-10 2008-03-10

Publications (1)

Publication Number Publication Date
PA8776001A1 true PA8776001A1 (en) 2008-11-19

Family

ID=40513718

Family Applications (1)

Application Number Title Priority Date Filing Date
PA8776001A PA8776001A1 (en) 2007-04-05 2008-04-07 NEW DROSPIRENONA REGIME / 17b- ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND ELEMENT ASSEMBLY (KIT) FOR APPLICATION

Country Status (2)

Country Link
PA (1) PA8776001A1 (en)
RU (1) RU2009140372A (en)

Also Published As

Publication number Publication date
RU2009140372A (en) 2011-05-10

Similar Documents

Publication Publication Date Title
BRPI0516238A (en) pharmaceutical composition containing diclofenac
NI201100079A (en) ACETAMINOPHEN / TRAMADOL PROLONGED RELEASE ORAL DOSAGE FORM
MX2009010289A (en) COMPOSITIONS FOR NASAL ADMINISTRATION.
HN2011003195A (en) GPR MODULAR 119
UY32925A (en) ORAL ADMINISTRATION CORTICOSTEROID COMPOSITIONS
EA201100304A1 (en) DELIVERY SYSTEM OF MEDICINES CONTAINING PROGESTINS
AR062875A1 (en) N-METHYLAMINOMETIL ISOINDOL COMPOUNDS AND COMPOSITIONS THAT INCLUDE THEM AND METHODS TO USE THEM
CR11744A (en) LIQUID FORMULATION FOR DEFERIPRONE WITH NICE TASTE TO THE PALATE
GT201400059A (en) DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES
MX2010003441A (en) Galenical formulations of organic compounds.
HRP20041092B1 (en) New pharmaceutical compositions containing filbanserin polymorph a
BR112014014795A2 (en) immediate release multi-unit pellet system
BRPI0817275A2 (en) Pharmaceutical combination of aliskiren and valsartan
AR068368A1 (en) SOLID FORMS OF CONTROLLED LIBERATION AZITHROMYCIN DOSAGE
AR065971A1 (en) NEW DROSPERINONA / 17BETA-ESTRADIOL REGIME, COMBINED PHARMACEUTICAL PRODUCT AND SET OF ELEMENTS (KIT) FOR APPLICATION
ECSP088850A (en) FORMULATION OF LIQUID MEDICINAL PRODUCT
EA200701923A1 (en) DRUG FORM FOR THE ORAL ADMINISTRATION OF VITAMIN
AR062784A1 (en) TREATMENT OF THE VERTIGES WITH ACETIL -L- LEUCINA
CO6210807A2 (en) PHARMACEUTICAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF TRAMADOL AND KETOPROPHENE
MX2010001221A (en) THE APPLICATION OF 5-METHYL-1,3 BENZENEDIOL OR DERIVATIVES OF THE SAME, IN THE PREPARATION OF MEDICINES AND FUNCTIONAL FOODS FOR THE TREATMENT OR PREVENTION OF DEPRESSION.
PA8776001A1 (en) NEW DROSPIRENONA REGIME / 17b- ESTRADIOL, COMBINED PHARMACEUTICAL PRODUCT AND ELEMENT ASSEMBLY (KIT) FOR APPLICATION
ECSP21072036A (en) PHARMACEUTICAL COMPOSITION CONTAINING ACETAMINOPHEN AND IBUPROFEN
EA200901591A1 (en) PHARMACEUTICAL COMPOSITIONS OF DERIVATIVES OF S-ALKYLISOTIOURONIUM WITH MASKED TASTE
MX2009008813A (en) PHARMACEUTICAL COMPOSITION CONTAINING FLOROGLUCINOL AND PARACETAMOL.
PE20141688A1 (en) ANTINEURITIC PHARMACEUTICAL COMBINATION AND COMPOSITIONS